Human calcitonin (hCT) regulates calcium–phosphorus
metabolism,
but its amyloid aggregation disrupts physiological activity, increases
thyroid carcinoma risk, and hampers its clinical use for bone-related
diseases like osteoporosis and Paget’s disease. Improving hCT
with targeted modifications to mitigate amyloid formation while maintaining
its function holds promise as a strategy. Understanding how each residue
in hCT’s amyloidogenic core affects its structure and aggregation
dynamics is crucial for designing effective analogues. Mutants F16L-hCT
and F19L-hCT, where Phe residues in the core are replaced with Leu
as in nonamyloidogenic salmon calcitonin, showed different aggregation
kinetics. However, the molecular effects of these substitutions in
hCT are still unclear. Here, we systematically investigated the folding
and self-assembly conformational dynamics of hCT, F16L-hCT, and F19L-hCT
through multiple long-time scale independent atomistic discrete molecular
dynamics (DMD) simulations. Our results indicated that the hCT monomer
primarily assumed unstructured conformations with dynamic helices
around residues 4–12 and 14–21. During self-assembly,
the amyloidogenic core of hCT14–21 converted from
dynamic helices to β-sheets. However, substituting F16L did
not induce significant conformational changes, as F16L-hCT exhibited
characteristics similar to those of wild-type hCT in both monomeric
and oligomeric states. In contrast, F19L-hCT exhibited substantially
more helices and fewer β-sheets than did hCT, irrespective of
their monomers or oligomers. The substitution of F19L significantly
enhanced the stability of the helical conformation for hCT14–21, thereby suppressing the helix-to-β-sheet conformational conversion.
Overall, our findings elucidate the molecular mechanisms underlying
hCT aggregation and the effects of F16L and F19L substitutions on
the conformational dynamics of hCT, highlighting the critical role
of F19 as an important target in the design of amyloid-resistant hCT
analogs for future clinical applications.